16-hydroxyandrost-4-en-3,17-dione is a **steroid hormone** with a chemical structure similar to testosterone. It's also known as **16α-hydroxytestosterone**.
**Here's why it's important for research:**
* **Potential Therapeutic Applications:** Research suggests 16-hydroxyandrost-4-en-3,17-dione might have potential therapeutic applications for:
* **Muscle growth and strength:** It's shown to have anabolic effects, potentially aiding muscle development.
* **Neuroprotection:** Some studies suggest it may protect brain cells from damage.
* **Treating certain cancers:** There's evidence of anti-cancer activity against some types of tumors.
* **Metabolic Effects:** It's also being studied for its role in metabolism and its possible effects on things like:
* **Lipid profiles (cholesterol, triglycerides, etc.)**
* **Glucose regulation**
* **Understanding Steroid Metabolism:** Research on 16-hydroxyandrost-4-en-3,17-dione can help scientists better understand the complex processes of steroid metabolism in the body. This knowledge could have implications for:
* **Developing more effective drugs**
* **Preventing and treating steroid-related diseases**
**It's important to note:**
* **Clinical Research is Ongoing:** Much of the research on 16-hydroxyandrost-4-en-3,17-dione is still in early stages, and more studies are needed to fully understand its safety, effectiveness, and potential applications.
* **Potential Side Effects:** As with any steroid hormone, 16-hydroxyandrost-4-en-3,17-dione could have potential side effects. Further research is needed to determine the risks associated with its use.
**Overall, 16-hydroxyandrost-4-en-3,17-dione is an intriguing molecule with potential therapeutic benefits. Continued research is crucial to understand its full potential and ensure its safe and effective use.**
16-hydroxyandrost-4-en-3,17-dione: RN given refers to cpd without isomeric designation; structure
ID Source | ID |
---|---|
PubMed CID | 160789 |
MeSH ID | M0069505 |
Synonym |
---|
16-hydroxyandrost-4-ene-3,17-dione |
5746-45-2 |
16-hydroxyandrost-4-en-3,17-dione |
16alpha-hydroxyandrost-4-en-3,17-dione |
16alpha-ohad |
DTXSID30972943 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 8 (42.11) | 18.7374 |
1990's | 4 (21.05) | 18.2507 |
2000's | 6 (31.58) | 29.6817 |
2010's | 1 (5.26) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.15) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 20 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |